ArticleJournal of biosciences2026
PPE18 protein of Mycobacterium tuberculosis downregulates LPS-induced IgG production by inhibiting nitric oxide synthesis.
Article in Journal of biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycobacterial PPE18 is a virulence factor. Previous studies have demonstrated that recombinant PPE18 protein (rPPE18) downregulates inflammation-induced nitric oxide synthase (iNOS) and nitric oxide (NO) production. Given its ability to inhibit iNOS, we investigated whether rPPE18 can also affect IgG secretion, which is modulated by NO levels. Mouse splenocytes and purified B cells were stimulated with lipopolysaccharide (LPS) to induce iNOS-mediated NO as well as IgG and IgM production. The addition of rPPE18 to LPS-stimulated cells reduced NO and iNOS at both the transcript and protein levels. This was accompanied by a drop in total secreted IgG, which could be reversed by the addition of SNAP, an NO donor. Importantly, rPPE18 did not affect secreted IgM levels. These data suggest that rPPE18 interferes with NO-dependent antibody class-switching from IgM to IgG. This was further confirmed by significantly reduced transcript levels of activation-induced cytidine deaminase (AID) in rPPE18-treated LPS-stimulated splenocytes. AID is crucial for class-switch recombination and is regulated by NO levels. These data highlight a novel mycobacterial virulence mechanism, in which rPPE18 inhibits IgG secretion and dampens protective humoral immunity, which is a critical component of the host anti-mycobacterial response.
Indexed as
Identifiers
42544498What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.